Nonin Medical's Philip Isaacson Expands CEO Role; President and COO Steve Bucholz to Retire May 1
MINNEAPOLIS, April 17, 2015 /PRNewswire/ -- Nonin Medical, a global leader in noninvasive medical monitoring, today announced that President and Chief Operating Officer Steve Bucholz will retire May 1. Company founder Philip Isaacson is expanding his role as Chief Executive Officer. In addition, Mr. Isaacson will continue in his role as Chief Technology Officer. Operations will transition to David Noel, Chief Financial Officer.
"Steve Bucholz has been instrumental to Nonin Medical's growth," Mr. Isaacson said. "Under Steve's leadership, he assembled an extremely well qualified senior leadership team and Nonin launched a number of innovative oximetry and mHealth solutions, developed device interoperability standards, expanded its product portfolio globally and partnered with key industry leaders to further our mission of improving the quality of people's lives. I am grateful for Steve's 28 years of service."
Mr. Isaacson established Nonin Medical in 1986 with three engineers; Mr. Bucholz joined the company as Operations Manager the following year. Together, they introduced the world's first finger pulse oximeter and helped Nonin became globally recognized for its advanced signal processing and sensor design—patented technology known for providing superior monitoring performance in challenging patients and conditions.
About Nonin Medical, Inc.
Nonin Medical, Inc. invented finger pulse oximetry and specializes in the design and manufacturing of noninvasive physiological monitoring solutions. Headquartered in Minneapolis, Minn. with an additional distribution and service center in Amsterdam, Netherlands, Nonin distributes its pulse and cerebral oximeters, capnographs, sensors and software to health professionals and consumers in more than 125 countries and has more than 200 OEM partners worldwide. For more information, visit www.nonin.com.
Photo - http://photos.prnewswire.com/prnh/20150417/199385
Logo - http://photos.prnewswire.com/prnh/20140626/122207
SOURCE Nonin Medical, Inc.
Share this article